RxDoctor Payments Data

Richard Kennedy, MD

Family Medicine · Columbia, TNNPI 1215029897

Payments from drug & device makers

$14,177in general payments, 2019–2025

Across 825 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • AbbVie$1K
  • Novo Nordisk$1K
  • Lilly USA, LLC$882
  • Boehringer Ingelheim$779
  • Pfizer$741
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$13,87398%
  • Education$3042%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca85$1,461
AbbVie(2 entities)76$1,139
Novo Nordisk65$1,096
Lilly USA, LLC45$882
Boehringer Ingelheim47$779
Pfizer54$741
Amgen43$721
Johnson & Johnson(2 entities)51$695
Astellas Pharma US Inc18$477
GSK24$449
Xeris Pharmaceuticals, Inc.18$441
E.r. Squibb & Sons, L.L.C.29$385
Takeda Pharmaceuticals U.S.A., Inc.17$367
Bayer18$361
Sanofi-aventis U.S. LLC23$355
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC18$300
Abbott14$276
Esperion Therapeutics, Inc.13$233
Novartis11$213
Sunovion Pharmaceuticals Inc.13$208
Nestle Healthcare Nutrition Inc.10$190
Merck11$179
Ironwood Pharmaceuticals, Inc10$174
Exact Sciences7$144
Mylan Specialty L.p.5$131
Teva Pharmaceuticals USA, Inc.6$122
Eisai Inc.7$116
Lundbeck LLC7$114
Otsuka America Pharmaceutical, Inc.5$113
Supernus Pharmaceuticals, Inc.7$107
Aimmune Therapeutics, Inc.7$105
Boston Scientific4$99
Amarin Pharma, Inc.4$87
Biohaven Pharmaceutical Holding Company Ltd.4$69
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$61
Daiichi Sankyo Inc.3$59
Shield Therapeutics Inc3$56
Phathom Pharmaceuticals, Inc.3$52
Circassia Inc.3$52
Acadia Pharmaceuticals Inc3$50
Dexcom, Inc.3$48
Genentech USA, Inc.3$48
Grifols USA, LLC2$45
Corcept Therapeutics2$38
Insulet Corporation2$38
Kowa Pharmaceuticals America, Inc.2$32
Sumitomo Pharma America, Inc.2$31
Phadia US Inc.2$28
Inspire Medical Systems, Inc.1$27
Nevro Corp.1$24
Urovant Sciences Inc1$20
Biohaven Pharmaceuticals, Inc.1$19
Bardy Diagnostics, Inc.2$19
Antares Pharma, Inc.1$17
Acorda Therapeutics, Inc1$16
Cranial Technologies, Inc1$16
Paratek Pharmaceuticals, Inc.1$16
UCB, Inc.1$13
Amneal Pharmaceuticals LLC1$12
Apria Healthcare LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,177 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$353,354
Medicare patients
638
Services billed
8,044

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide146$234,889
EliquisApixaban279$230,421
JardianceEmpagliflozin186$202,336
XareltoRivaroxaban136$120,241
MounjaroTirzepatide59$101,154
Trelegy ElliptaFluticasone/Umeclidin/Vilanter97$99,808
FarxigaDapagliflozin Propanediol85$75,394
OtezlaApremilast13$60,596
TrulicityDulaglutide34$48,481
LinzessLinaclotide58$46,174
JanuviaSitagliptin Phosphate79$35,474
Tresiba Flextouch U-100Insulin Degludec52$34,129
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$31,028
TradjentaLinagliptin44$27,931
EntrestoSacubitril/Valsartan51$27,429

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,096$258,885160 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$779$250,791252 claims
PfizerEliquis, Abrysvo$741$245,038325 claims
Lilly USA, LLCMounjaro, Trulicity$882$149,63593 claims
Johnson & JohnsonXarelto, Invokana$695$136,400148 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$449$119,795143 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,461$108,182137 claims
AmgenOtezla$721$60,59613 claims
AbbVieLinzess$1,139$46,17458 claims
MerckJanuvia$179$35,47479 claims
NovartisEntresto$213$27,42951 claims
Astellas Pharma US IncMyrbetriq$477$14,92825 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Columbia

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →